Advertisement
ABT vs BDX
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABT is a Hold and BDX is a Hold.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
ABT’s FA Score shows that 2 FA rating(s) are green whileBDX’s FA Score has 1 green FA rating(s).
- ABT’s FA Score: 2 green, 3 red.
- BDX’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
ABT’s TA Score shows that 2 TA indicator(s) are bullish while BDX’s TA Score has 3 bullish TA indicator(s).
- ABT’s TA Score: 2 bullish, 6 bearish.
- BDX’s TA Score: 3 bullish, 7 bearish.
Price Growth
ABT (@Medical/Nursing Services) experienced а -2.61% price change this week, while BDX (@Pharmaceuticals: Other) price change was +1.36% for the same time period.
The average weekly price growth across all stocks in the @Medical/Nursing Services industry was +1.22%. For the same industry, the average monthly price growth was +3.46%, and the average quarterly price growth was +18.57%.
The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -0.29%. For the same industry, the average monthly price growth was +0.51%, and the average quarterly price growth was +14.72%.
Reported Earning Dates
ABT is expected to report earnings on Jan 28, 2026.
BDX is expected to report earnings on Nov 06, 2025.
Industries' Descriptions
@Medical/Nursing Services (+1.22% weekly)The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.
@Pharmaceuticals: Other (-0.29% weekly)Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.
| ABT | BDX | ABT / BDX | |
| Capitalization | 224B | 54.2B | 413% |
| EBITDA | 11.6B | 4.92B | 236% |
| Gain YTD | 15.795 | -15.306 | -103% |
| P/E Ratio | 16.13 | 34.57 | 47% |
| Revenue | 43.1B | 21.4B | 201% |
| Total Cash | N/A | N/A | - |
| Total Debt | 13.4B | 19.3B | 69% |
ABT | BDX | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 65 | 12 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 16 Undervalued | 21 Undervalued | |
PROFIT vs RISK RATING 1..100 | 54 | 100 | |
SMR RATING 1..100 | 31 | 82 | |
PRICE GROWTH RATING 1..100 | 56 | 58 | |
P/E GROWTH RATING 1..100 | 96 | 81 | |
SEASONALITY SCORE 1..100 | 50 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
ABT's Valuation (16) in the Medical Specialties industry is in the same range as BDX (21). This means that ABT’s stock grew similarly to BDX’s over the last 12 months.
ABT's Profit vs Risk Rating (54) in the Medical Specialties industry is somewhat better than the same rating for BDX (100). This means that ABT’s stock grew somewhat faster than BDX’s over the last 12 months.
ABT's SMR Rating (31) in the Medical Specialties industry is somewhat better than the same rating for BDX (82). This means that ABT’s stock grew somewhat faster than BDX’s over the last 12 months.
ABT's Price Growth Rating (56) in the Medical Specialties industry is in the same range as BDX (58). This means that ABT’s stock grew similarly to BDX’s over the last 12 months.
BDX's P/E Growth Rating (81) in the Medical Specialties industry is in the same range as ABT (96). This means that BDX’s stock grew similarly to ABT’s over the last 12 months.
| ABT | BDX | |
|---|---|---|
| RSI ODDS (%) | N/A | 3 days ago 57% |
| Stochastic ODDS (%) | 3 days ago 55% | 3 days ago 43% |
| Momentum ODDS (%) | 3 days ago 44% | 3 days ago 44% |
| MACD ODDS (%) | 3 days ago 45% | 3 days ago 51% |
| TrendWeek ODDS (%) | 3 days ago 50% | 3 days ago 44% |
| TrendMonth ODDS (%) | 3 days ago 48% | 3 days ago 44% |
| Advances ODDS (%) | 28 days ago 56% | 6 days ago 44% |
| Declines ODDS (%) | 7 days ago 50% | 4 days ago 37% |
| BollingerBands ODDS (%) | 3 days ago 53% | 3 days ago 45% |
| Aroon ODDS (%) | N/A | 3 days ago 35% |
Advertisement
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| NFTY | 59.43 | 0.53 | +0.90% |
| First Trust India NIFTY 50 Equal Wtd ETF | |||
| IQDF | 28.78 | 0.19 | +0.66% |
| FlexShares Intl Qual Div ETF | |||
| SCHB | 25.63 | 0.12 | +0.47% |
| Schwab US Broad Market ETF™ | |||
| HEJD | 26.96 | N/A | N/A |
| VictoryShares Hedged Equity Income ETF | |||
| EWUS | 40.90 | -0.22 | -0.54% |
| iShares MSCI United Kingdom Small-Cp ETF | |||